editorial
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
editorial
Jun 22, 2024, 02:24 |
Insight
Guru Sonpavde: ctDNA for Evaluating Minimal Residual Disease in Bladder Cancer
Guru Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, posted on…
Jun 21, 2024, 09:25 |
Blog
Thank you Lancet Oncology for the shout out in the latest editorial - Common Sense Oncology
Common Sense Oncology posted on X: "Thank you The Lancet Oncology for the shout out…
May 24, 2024, 14:15 |
Blog
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X: “Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the…
May 14, 2024, 12:51 |
Blog
Vivek Subbiah: About time for precision immunotherapy
Vivek Subbiah shared a post on LinkedIn: “Sharing our editorial: Rationalizing rules for immunotherapy combination trials:…
May 11, 2024, 12:05 |
Blog
Nina Niu Sanford: Nice editorial urging caution in patients with near CR after total neoadjuvant therapy in rectal cancer
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a…
Apr 13, 2024, 13:34 |
Blog
Vivek Subbiah: An editorial describes the science behind one strategy using a CAR T cell
Vivek Subbiah shared on X/Twitter: "Most patients diagnosed with glioblastoma die within a year, so innovative…
Mar 30, 2024, 09:36 |
Blog
Ramy Sedhom: Thoughtful editorial I missed in 2020! 'When Cancer Centers Mislead Prospective Patients'
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a post…
Mar 21, 2024, 16:09 |
Insight
Bishal Gyawali: A pleasure to write this editorial with the brilliant Nina Niu Sanford on how to manage FCOI in oncology
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: “Hot…
All:
8
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube